ChemotherapyBone marrow transplantation procedure has emerged as an effective treatment for hematological malignancies. However, recurrence of leukemia is still the major cause of treatment failure. Subsequent treatment in this category of patients, generally considered incurable, has not been yet ...
Aggressive combination chemotherapy can produce long-term survival in selected patients relapsed after BMT.Eight patients, 5 with acute non lymphoid leukemia and 3 with lymphoid leukemia, were treated at relapse after bone marrow transplantation (BMT; 4 autologous BMT and 4 allogeneic BMT). Of...
The first treatment of choice for leukemia is usually chemotherapy, as it can be used against all forms of leukemia at all stages. If the patient does not respond well to chemotherapy, other treatment options like radiotherapy or bone marrow transplant may be used. ...
We describe in details our regimens for induction chemotherapy and perform a review of existing literature concerning treatment of aggressive NK-cell leukemia. 展开 关键词: Internal Medicine Gastroenterology and Hepatology DOI: 10.1155/2011/818469 被引量: 3 ...
Researchers have identified a key weakness in acute myeloid leukemia, offering a promising new strategy to delay the progression of this aggressive blood cancer. The discovery focuses on disrupting the function of a certain protein complex that cancer ce
SCC is now considered the prototype for t... MG Zampino,E Magni,A Sonzogni,... - 《Cancer Chemotherapy & Pharmacology》 被引量: 53发表: 2009年 Discoid lupus erythematosus with squamous cell carcinoma: a case report and review of the literature in Indian patients. after excision.We ...
The protein BCL-2 is also necessary for survival of T-PLL cells, which is why venetoclax also specifically eliminatescancer cellsin this form of leukaemia. Another advantage is that, in contrast to chemotherapy, treatment with thisdrugonly causes minimal side-effects in patients. Moreover, two ...
Long-lasting complete remission in plasma cell leukemia after aggressive chemotherapy and CD34-selected autologous peripheral cell transplant: molecular follow-up of minimal residual disease. Bone Marrow Transplant. 1998; 22 (8):823–5. [ PubMed ]...
The chemotherapy on plasma-cell myeloma and the incidence of acute leukemia. Previously untreated patients with myeloma were randomized to initial treatment with melphalan and prednisone (and to cyclophosphamide or carmustine if relapse or progression occurred)(Group A, 125 patients), melphalan, cyclophos...
There are fewtreatment optionsfor AML. Therapies have remained relatively unchanged for the last 30 years, with the majority of patients receiving chemotherapy and bone marrow transplants to control their condition. Unfortunately, many of these treatments are not effective and they cause toxic, and ...